The Department of Health and Human Services this week purchased $26 million worth of intravenous TPOXX (tecovirimat) to treat monkeypox, which the manufacturer expects to deliver next year. Under its contract with SIGA Technologies, HHS may still purchase additional oral and IV TPOXX, an antiviral drug approved by the Food and Drug Administration to treat smallpox and available under an investigational protocol to treat monkeypox. TPOXX is available free to states and territories through the Strategic National Stockpile, which held over 1.7 million treatment courses before the monkeypox outbreak. HHS last week declared the U.S. outbreak, which exceeds 10,000 cases, a public health emergency. 

Headline
The Wisconsin Department of Health Services announced Nov. 13 that a second child in the state died of measles amid its ongoing outbreak. As of Nov. 13, the…
Headline
Pennsylvania has recorded its seventh measles-associated death this year as a statewide outbreak of the virus continues, according to an update Nov. 13 by the…
Headline
The Wisconsin Department of Health Services reported Nov. 5 that an infant died of measles, marking the first measles-associated death in the state since 1990.…
Headline
The New York State Department of Health announced Nov. 2 that a child died of measles amid the state’s ongoing outbreak and is the first known measles…
Headline
There have been 1,398 confirmed cases of measles in Pennsylvania this year, according to data released Oct. 28 by the Pennsylvania Department of Health. Data…
Headline
The Centers for Disease Control and Prevention reported 798 laboratory-confirmed flu-associated hospitalizations for the week ending Oct. 17. The weekly…